|
EC Seeks Faster Turnaround on Pricing, Reimbursement Decisions
Drug sponsors may be able to bring novel and generic drugs to market earlier in the EU and be eligible for damages if states don’t meet deadlines for pricing and reimbursement decisions, under proposed legislation adopted by the European Commission March 1.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives